These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Striatal and extrastriatal imaging of dopamine D2 receptors in the living human brain with [123I]epidepride single-photon emission tomography. Kuikka JT; Akerman KK; Hiltunen J; Bergström KA; Räsänen P; Vanninen E; Halldin C; Tiihonen J Eur J Nucl Med; 1997 May; 24(5):483-7. PubMed ID: 9142727 [TBL] [Abstract][Full Text] [Related]
5. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D(2) receptors in human brain. de Paulis T Curr Pharm Des; 2003; 9(8):673-96. PubMed ID: 12570798 [TBL] [Abstract][Full Text] [Related]
6. A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Verhoeff NP; Kapur S; Hussey D; Lee M; Christensen B; C Psych ; Papatheodorou G; Zipursky RB Neuropsychopharmacology; 2001 Aug; 25(2):213-23. PubMed ID: 11425505 [TBL] [Abstract][Full Text] [Related]
7. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients. Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302 [TBL] [Abstract][Full Text] [Related]
8. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO. Caravaggio F; Nakajima S; Borlido C; Remington G; Gerretsen P; Wilson A; Houle S; Menon M; Mamo D; Graff-Guerrero A Neuropsychopharmacology; 2014 Nov; 39(12):2769-76. PubMed ID: 24874713 [TBL] [Abstract][Full Text] [Related]
9. Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D2 receptor binding with [123I]epidepride SPECT. Ichise M; Fujita M; Seibyl JP; Verhoeff NP; Baldwin RM; Zoghbi SS; Rajeevan N; Charney DS; Innis RB J Nucl Med; 1999 Nov; 40(11):1902-12. PubMed ID: 10565788 [TBL] [Abstract][Full Text] [Related]
10. Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans. Cropley VL; Innis RB; Nathan PJ; Brown AK; Sangare JL; Lerner A; Ryu YH; Sprague KE; Pike VW; Fujita M Synapse; 2008 Jun; 62(6):399-408. PubMed ID: 18361438 [TBL] [Abstract][Full Text] [Related]
11. Striatal dopamine D2/3 receptor binding following dopamine depletion in subjects at Ultra High Risk for psychosis. Bloemen OJ; de Koning MB; Gleich T; Meijer J; de Haan L; Linszen DH; Booij J; van Amelsvoort TA Eur Neuropsychopharmacol; 2013 Feb; 23(2):126-32. PubMed ID: 22591910 [TBL] [Abstract][Full Text] [Related]
12. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride. Kessler RM; Whetsell WO; Ansari MS; Votaw JR; de Paulis T; Clanton JA; Schmidt DE; Mason NS; Manning RG Brain Res; 1993 Apr; 609(1-2):237-43. PubMed ID: 8099521 [TBL] [Abstract][Full Text] [Related]
13. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls. Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391 [TBL] [Abstract][Full Text] [Related]
14. No effect of dopamine depletion on the binding of the high-affinity D 2/3 radiotracer [11C]FLB 457 in the human cortex. Frankle WG; Mason NS; Rabiner EA; Ridler K; May MA; Asmonga D; Chen CM; Kendro S; Cooper TB; Mathis CA; Narendran R Synapse; 2010 Dec; 64(12):879-85. PubMed ID: 20506387 [TBL] [Abstract][Full Text] [Related]
15. [123I]epidepride binding to cerebellar dopamine D2/D3 receptors is displaceable: implications for the use of cerebellum as a reference region. Pinborg LH; Videbaek C; Ziebell M; Mackeprang T; Friberg L; Rasmussen H; Knudsen GM; Glenthoj BY Neuroimage; 2007 Feb; 34(4):1450-3. PubMed ID: 17175177 [TBL] [Abstract][Full Text] [Related]
16. High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain. Kessler RM; Votaw JR; Schmidt DE; Ansari MS; Holdeman KP; de Paulis T; Clanton JA; Pfeffer R; Manning RG; Ebert MH Life Sci; 1993; 53(3):241-50. PubMed ID: 8321085 [TBL] [Abstract][Full Text] [Related]
17. AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures. Boot E; Booij J; Hasler G; Zinkstok JR; de Haan L; Linszen DH; van Amelsvoort TA Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1350-6. PubMed ID: 18283451 [TBL] [Abstract][Full Text] [Related]
18. Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging. Leslie WD; Abrams DN; Greenberg CR; Hobson D J Nucl Med; 1996 Oct; 37(10):1589-91. PubMed ID: 8862288 [TBL] [Abstract][Full Text] [Related]
19. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine. Tuppurainen H; Kuikka JT; Viinamäki H; Husso M; Tiihonen J Psychiatry Clin Neurosci; 2009 Aug; 63(4):529-37. PubMed ID: 19496999 [TBL] [Abstract][Full Text] [Related]
20. Visualization of extrastriatal dopamine D2 receptors in the human brain. Kessler RM; Mason NS; Votaw JR; De Paulis T; Clanton JA; Ansari MS; Schmidt DE; Manning RG; Bell RL Eur J Pharmacol; 1992 Nov; 223(1):105-7. PubMed ID: 1478255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]